During the past decade, White Wilson Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "White Wilson Medical Center" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "CTI-1, LLC" with 1 trials sponsored, "Mt. Sinai Medical Center, Miami" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "White Wilson Medical Center" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "White Wilson Medical Center" are "Hypertension" (2 trials), "Alzheimer's Disease" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Congestive Heart Failure" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "White Wilson Medical Center" in a lesser frequency.

Most popular intervention types in "White Wilson Medical Center" are "Drug" (7 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "placebo" (2 trials), "Darusentan Placebo" (1 trials), "EDTA" (1 trials) and "EDTA Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "White Wilson Medical Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "White Wilson Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in White Wilson Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in White Wilson Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".